Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Porphyromonas gingivalis Gingipains Display Transpeptidation Activity.

Zhang L, Veith PD, Huq NL, Chen YY, Seers CA, Cross KJ, Gorasia DG, Reynolds EC.

J Proteome Res. 2018 Aug 3;17(8):2803-2818. doi: 10.1021/acs.jproteome.8b00286. Epub 2018 Jul 20.

PMID:
29984580
2.

A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis.

O'Brien-Simpson NM, Holden JA, Lenzo JC, Tan Y, Brammar GC, Walsh KA, Singleton W, Orth RKH, Slakeski N, Cross KJ, Darby IB, Becher D, Rowe T, Morelli AB, Hammet A, Nash A, Brown A, Ma B, Vingadassalom D, McCluskey J, Kleanthous H, Reynolds EC.

NPJ Vaccines. 2016 Dec 1;1:16022. doi: 10.1038/npjvaccines.2016.22. eCollection 2016.

3.

Porphyromonas gingivalis Uses Specific Domain Rearrangements and Allelic Exchange to Generate Diversity in Surface Virulence Factors.

Dashper SG, Mitchell HL, Seers CA, Gladman SL, Seemann T, Bulach DM, Chandry PS, Cross KJ, Cleal SM, Reynolds EC.

Front Microbiol. 2017 Jan 26;8:48. doi: 10.3389/fmicb.2017.00048. eCollection 2017.

4.

PG1058 Is a Novel Multidomain Protein Component of the Bacterial Type IX Secretion System.

Heath JE, Seers CA, Veith PD, Butler CA, Nor Muhammad NA, Chen YY, Slakeski N, Peng B, Zhang L, Dashper SG, Cross KJ, Cleal SM, Moore C, Reynolds EC.

PLoS One. 2016 Oct 6;11(10):e0164313. doi: 10.1371/journal.pone.0164313. eCollection 2016.

5.

Casein Phosphopeptide-Amorphous Calcium Phosphate Nanocomplexes: A Structural Model.

Cross KJ, Huq NL, Reynolds EC.

Biochemistry. 2016 Aug 9;55(31):4316-25. doi: 10.1021/acs.biochem.6b00522. Epub 2016 Aug 1.

PMID:
27434168
6.

The Interactions of CPP-ACP with Saliva.

Huq NL, Myroforidis H, Cross KJ, Stanton DP, Veith PD, Ward BR, Reynolds EC.

Int J Mol Sci. 2016 Jun 9;17(6). pii: E915. doi: 10.3390/ijms17060915.

7.

Frequency of asthma education in primary care in the years 2007-2010.

Lee MG, Cross KJ, Yang WY, Sutton BS, Jiroutek MR.

J Asthma. 2016;53(2):220-6. doi: 10.3109/02770903.2015.1087024. Epub 2015 Sep 18.

PMID:
26313596
8.

Structure of the lysine specific protease Kgp from Porphyromonas gingivalis, a target for improved oral health.

Gorman MA, Seers CA, Michell BJ, Feil SC, Huq NL, Cross KJ, Reynolds EC, Parker MW.

Protein Sci. 2015 Jan;24(1):162-6. doi: 10.1002/pro.2589. Epub 2014 Dec 3.

9.

Bioinformatic investigation of the cost management strategies of five oral microbes.

Cross KJ, Huq NL, Park SH, Park JS, Pham P, Quah M, Ranjan M, Reynolds EC.

Mol Oral Microbiol. 2015 Apr;30(2):87-96. doi: 10.1111/omi.12071. Epub 2014 Oct 9.

PMID:
25052707
10.

Propeptide-mediated inhibition of cognate gingipain proteinases.

Huq NL, Seers CA, Toh EC, Dashper SG, Slakeski N, Zhang L, Ward BR, Meuric V, Chen D, Cross KJ, Reynolds EC.

PLoS One. 2013 Jun 10;8(6):e65447. doi: 10.1371/journal.pone.0065447. Print 2013.

11.

Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

Dashper SG, Pan Y, Veith PD, Chen YY, Toh EC, Liu SW, Cross KJ, Reynolds EC.

Antimicrob Agents Chemother. 2012 Mar;56(3):1548-56. doi: 10.1128/AAC.05100-11. Epub 2012 Jan 3.

12.

The outer membrane protein LptO is essential for the O-deacylation of LPS and the co-ordinated secretion and attachment of A-LPS and CTD proteins in Porphyromonas gingivalis.

Chen YY, Peng B, Yang Q, Glew MD, Veith PD, Cross KJ, Goldie KN, Chen D, O'Brien-Simpson N, Dashper SG, Reynolds EC.

Mol Microbiol. 2011 Mar;79(5):1380-401. doi: 10.1111/j.1365-2958.2010.07530.x. Epub 2011 Jan 18.

13.

Porphyromonas gingivalis cysteine proteinase inhibition by kappa-casein peptides.

Toh EC, Dashper SG, Huq NL, Attard TJ, O'Brien-Simpson NM, Chen YY, Cross KJ, Stanton DP, Paolini RA, Reynolds EC.

Antimicrob Agents Chemother. 2011 Mar;55(3):1155-61. doi: 10.1128/AAC.00466-10. Epub 2010 Dec 20.

14.

Nasal spreader grafts: a comparison of medpor to autologous tissue reconstruction.

Reiffel AJ, Cross KJ, Spinelli HM.

Ann Plast Surg. 2011 Jan;66(1):24-8. doi: 10.1097/SAP.0b013e3181d3ef8e.

PMID:
21102310
15.

Optical fiber imaging for high speed plasma motion diagnostics: applied to low voltage circuit breakers.

McBride JW, Balestrero A, Ghezzi L, Tribulato G, Cross KJ.

Rev Sci Instrum. 2010 May;81(5):055109. doi: 10.1063/1.3428737.

PMID:
20515174
16.

Structural basis of the 1H-nuclear magnetic resonance spectra of ethanol-water solutions based on multivariate curve resolution analysis of mid-infrared spectra.

Hu N, Wu D, Cross KJ, Schaefer DW.

Appl Spectrosc. 2010 Mar;64(3):337-42. doi: 10.1366/000370210790918373.

PMID:
20223071
17.

Composition and functions of the influenza fusion peptide.

Cross KJ, Langley WA, Russell RJ, Skehel JJ, Steinhauer DA.

Protein Pept Lett. 2009;16(7):766-78. Review.

PMID:
19601906
18.

The absorbable dermal staple device: a faster, more cost-effective method for incisional closure.

Cross KJ, Teo EH, Wong SL, Lambe JS, Rohde CH, Grant RT, Ascherman JA.

Plast Reconstr Surg. 2009 Jul;124(1):156-62. doi: 10.1097/PRS.0b013e3181a805c5.

PMID:
19568054
19.

Gene therapy in skin: choosing the optimal viral vector.

Teo EH, Cross KJ, Bomsztyk ED, Lyden DC, Spector JA.

Ann Plast Surg. 2009 May;62(5):576-80. doi: 10.1097/SAP.0b013e31819fafbd.

PMID:
19387165
20.

A novel method for targeted gene therapy in ischemic tissues through viral transfection of an expression cassette containing multiple repetitions of hypoxia response element.

Cross KJ, Bomsztyk ED, Weinstein AL, Teo EH, Spector JA, Lyden DC.

Plast Reconstr Surg. 2009 Feb;123(2 Suppl):76S-82S. doi: 10.1097/PRS.0b013e318191c044.

PMID:
19182666
21.

Enamel subsurface lesion remineralisation with casein phosphopeptide stabilised solutions of calcium, phosphate and fluoride.

Cochrane NJ, Saranathan S, Cai F, Cross KJ, Reynolds EC.

Caries Res. 2008;42(2):88-97. doi: 10.1159/000113161. Epub 2008 Jan 15.

PMID:
18204252
22.

Effect of addition of citric acid and casein phosphopeptide-amorphous calcium phosphate to a sugar-free chewing gum on enamel remineralization in situ.

Cai F, Manton DJ, Shen P, Walker GD, Cross KJ, Yuan Y, Reynolds C, Reynolds EC.

Caries Res. 2007;41(5):377-83.

PMID:
17713338
23.

Casein phosphopeptides in oral health--chemistry and clinical applications.

Cross KJ, Huq NL, Reynolds EC.

Curr Pharm Des. 2007;13(8):793-800. Review.

PMID:
17430181
24.

Hypopharyngeal rupture secondary to blunt trauma: presentation, evaluation, and management.

Cross KJ, Koomalsingh KJ, Fahey TJ 3rd, Sample J.

J Trauma. 2007 Jan;62(1):243-6. Review. No abstract available.

PMID:
17215764
25.

Protein dynamics of bovine dentin phosphophoryn.

Cross KJ, Huq NL, Reynolds EC.

J Pept Res. 2005 Aug;66(2):59-67.

PMID:
16000119
26.

Association of bovine dentine phosphophoryn with collagen fragments.

Huq NL, Loganathan A, Cross KJ, Chen YY, Johnson NI, Willetts M, Veith PD, Reynolds EC.

Arch Oral Biol. 2005 Sep;50(9):807-19.

PMID:
15970211
27.

Divalent metal cations increase the activity of the antimicrobial Peptide kappacin.

Dashper SG, O'Brien-Simpson NM, Cross KJ, Paolini RA, Hoffmann B, Catmull DV, Malkoski M, Reynolds EC.

Antimicrob Agents Chemother. 2005 Jun;49(6):2322-8.

28.
29.

Physicochemical characterization of casein phosphopeptide-amorphous calcium phosphate nanocomplexes.

Cross KJ, Huq NL, Palamara JE, Perich JW, Reynolds EC.

J Biol Chem. 2005 Apr 15;280(15):15362-9. Epub 2005 Jan 17.

30.

Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers.

Vaccaro L, Cross KJ, Kleinjung J, Straus SK, Thomas DJ, Wharton SA, Skehel JJ, Fraternali F.

Biophys J. 2005 Jan;88(1):25-36. Epub 2004 Oct 8.

31.
32.

Molecular modelling of the multiphosphorylated casein phosphopeptide alphaS1-casein(59-79) based on NMR constraints.

Huq NL, Cross KJ, Reynolds EC.

J Dairy Res. 2004 Feb;71(1):28-32. No abstract available.

PMID:
15068063
33.

Platelet-derived growth factor B, but not fibroblast growth factor 2, plasmid DNA improves survival of ischemic myocutaneous flaps.

Hijjawi J, Mogford JE, Chandler LA, Cross KJ, Said H, Sosnowski BA, Mustoe TA.

Arch Surg. 2004 Feb;139(2):142-7. Erratum in: Arch Surg. 2004 May;139(5):468.

PMID:
14769570
34.

Hemoglobin hydrolysis and heme acquisition by Porphyromonas gingivalis.

Dashper SG, Cross KJ, Slakeski N, Lissel P, Aulakh P, Moore C, Reynolds EC.

Oral Microbiol Immunol. 2004 Feb;19(1):50-6.

PMID:
14678474
35.

Use of hypoxia-inducible factor signal transduction pathway to measure O2 levels and modulate growth factor pathways.

Mogford JE, Roy NK, Cross KJ, Mustoe TA.

Wound Repair Regen. 2003 Nov-Dec;11(6):496-503.

PMID:
14617292
36.

Mechanisms of cell entry by influenza virus.

Cross KJ, Burleigh LM, Steinhauer DA.

Expert Rev Mol Med. 2001 Aug 6;3(21):1-18. doi: 10.1017/S1462399401003453.

PMID:
14585145
37.

Nascent helix in the multiphosphorylated peptide alphaS2-casein(2-20).

Huq NL, Cross KJ, Reynolds EC.

J Pept Sci. 2003 Jun;9(6):386-92.

PMID:
12846484
38.

Growth factors in wound healing.

Cross KJ, Mustoe TA.

Surg Clin North Am. 2003 Jun;83(3):531-45, vi. Review.

PMID:
12822724
39.

CPG70 is a novel basic metallocarboxypeptidase with C-terminal polycystic kidney disease domains from Porphyromonas gingivalis.

Chen YY, Cross KJ, Paolini RA, Fielding JE, Slakeski N, Reynolds EC.

J Biol Chem. 2002 Jun 28;277(26):23433-40. Epub 2002 Apr 25.

40.

Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.

Cross KJ, Wharton SA, Skehel JJ, Wiley DC, Steinhauer DA.

EMBO J. 2001 Aug 15;20(16):4432-42.

41.

Kappacin, a novel antibacterial peptide from bovine milk.

Malkoski M, Dashper SG, O'Brien-Simpson NM, Talbo GH, Macris M, Cross KJ, Reynolds EC.

Antimicrob Agents Chemother. 2001 Aug;45(8):2309-15.

42.

Cation-dependent structural features of beta-casein-(1-25).

Cross KJ, Huq NL, Bicknell W, Reynolds EC.

Biochem J. 2001 May 15;356(Pt 1):277-86.

43.

N-terminal sequence analysis of bovine dentin phosphophoryn after conversion of phosphoseryl to S-propylcysteinyl residues.

Huq NL, Cross KJ, Talbo GH, Riley PF, Loganathan A, Crossley MA, Perich JW, Reynolds EC.

J Dent Res. 2000 Nov;79(11):1914-9.

PMID:
11145365
44.

Characterization of a novel outer membrane hemin-binding protein of Porphyromonas gingivalis.

Dashper SG, Hendtlass A, Slakeski N, Jackson C, Cross KJ, Brownfield L, Hamilton R, Barr I, Reynolds EC.

J Bacteriol. 2000 Nov;182(22):6456-62.

45.

A 1H-NMR study of the casein phosphopeptide alpha s1-casein(59-79).

Huq NL, Cross KJ, Reynolds EC.

Biochim Biophys Acta. 1995 Mar 15;1247(2):201-8.

PMID:
7696309
46.
47.

Selection by site-directed antibodies of small regions of peptides which are ordered in water.

Dyson HJ, Cross KJ, Ostresh J, Houghten RA, Wilson IA, Wright PE, Lerner RA.

Ciba Found Symp. 1986;119:58-75. Review.

PMID:
3525041
48.

The immunodominant site of a synthetic immunogen has a conformational preference in water for a type-II reverse turn.

Dyson HJ, Cross KJ, Houghten RA, Wilson IA, Wright PE, Lerner RA.

Nature. 1985 Dec 5-11;318(6045):480-3.

PMID:
4069219
49.

Assignment of acyl chain resonances from membranes of mammalian cells by two-dimensional NMR methods.

Cross KJ, Holmes KT, Mountford CE, Wright PE.

Biochemistry. 1984 Dec 4;23(25):5895-7.

PMID:
6525339
50.

An antibiotic interaction with ethinyloestradiol in the rat and rabbit.

Back DJ, Breckenbridge AM, Cross KJ, Orme ML, Thomas E.

J Steroid Biochem. 1982 Mar;16(3):407-13. No abstract available.

PMID:
7087468

Supplemental Content

Loading ...
Support Center